2-98377671-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001298.3(CNGA3):​c.102-16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0846 in 1,607,010 control chromosomes in the GnomAD database, including 6,199 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 566 hom., cov: 33)
Exomes 𝑓: 0.085 ( 5633 hom. )

Consequence

CNGA3
NM_001298.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.592

Publications

5 publications found
Variant links:
Genes affected
CNGA3 (HGNC:2150): (cyclic nucleotide gated channel subunit alpha 3) This gene encodes a member of the cyclic nucleotide-gated cation channel protein family which is required for normal vision and olfactory signal transduction. Mutations in this gene are associated with achromatopsia (rod monochromacy) and color blindness. Two alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
CNGA3 Gene-Disease associations (from GenCC):
  • achromatopsia 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia
  • CNGA3-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • achromatopsia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-98377671-A-G is Benign according to our data. Variant chr2-98377671-A-G is described in ClinVar as Benign. ClinVar VariationId is 257961.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNGA3NM_001298.3 linkc.102-16A>G intron_variant Intron 2 of 7 ENST00000272602.7 NP_001289.1 Q16281-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNGA3ENST00000272602.7 linkc.102-16A>G intron_variant Intron 2 of 7 1 NM_001298.3 ENSP00000272602.2 Q16281-1
CNGA3ENST00000436404.6 linkc.102-16A>G intron_variant Intron 2 of 6 1 ENSP00000410070.2 Q16281-2
CNGA3ENST00000409937.1 linkn.90-16A>G intron_variant Intron 1 of 7 2

Frequencies

GnomAD3 genomes
AF:
0.0791
AC:
12026
AN:
152110
Hom.:
565
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0493
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.0722
Gnomad ASJ
AF:
0.162
Gnomad EAS
AF:
0.139
Gnomad SAS
AF:
0.0539
Gnomad FIN
AF:
0.0748
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.0898
Gnomad OTH
AF:
0.0880
GnomAD2 exomes
AF:
0.0828
AC:
20163
AN:
243392
AF XY:
0.0841
show subpopulations
Gnomad AFR exome
AF:
0.0465
Gnomad AMR exome
AF:
0.0489
Gnomad ASJ exome
AF:
0.160
Gnomad EAS exome
AF:
0.146
Gnomad FIN exome
AF:
0.0744
Gnomad NFE exome
AF:
0.0879
Gnomad OTH exome
AF:
0.0955
GnomAD4 exome
AF:
0.0852
AC:
123923
AN:
1454782
Hom.:
5633
Cov.:
30
AF XY:
0.0852
AC XY:
61647
AN XY:
723200
show subpopulations
African (AFR)
AF:
0.0464
AC:
1549
AN:
33354
American (AMR)
AF:
0.0514
AC:
2278
AN:
44336
Ashkenazi Jewish (ASJ)
AF:
0.155
AC:
4036
AN:
26006
East Asian (EAS)
AF:
0.144
AC:
5688
AN:
39570
South Asian (SAS)
AF:
0.0612
AC:
5195
AN:
84908
European-Finnish (FIN)
AF:
0.0716
AC:
3797
AN:
53032
Middle Eastern (MID)
AF:
0.156
AC:
801
AN:
5140
European-Non Finnish (NFE)
AF:
0.0856
AC:
94921
AN:
1108356
Other (OTH)
AF:
0.0942
AC:
5658
AN:
60080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
5784
11567
17351
23134
28918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3462
6924
10386
13848
17310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0791
AC:
12035
AN:
152228
Hom.:
566
Cov.:
33
AF XY:
0.0790
AC XY:
5875
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0495
AC:
2056
AN:
41546
American (AMR)
AF:
0.0720
AC:
1101
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.162
AC:
561
AN:
3470
East Asian (EAS)
AF:
0.139
AC:
720
AN:
5178
South Asian (SAS)
AF:
0.0545
AC:
263
AN:
4824
European-Finnish (FIN)
AF:
0.0748
AC:
792
AN:
10592
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.0898
AC:
6106
AN:
68010
Other (OTH)
AF:
0.0885
AC:
187
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
559
1118
1676
2235
2794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0772
Hom.:
381
Bravo
AF:
0.0797
Asia WGS
AF:
0.122
AC:
425
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 15, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Achromatopsia 2 Benign:1
Apr 15, 2021
Molecular Genetics Laboratory, Institute for Ophthalmic Research
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
5.9
DANN
Benign
0.66
PhyloP100
0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2279859; hg19: chr2-98994134; API